Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 7.422 Q1 | 254 | 25 | 76 | 8872 | 1519 | 75 | 19.91 | 354.88 | 33.04 | |
2 | Report on carcinogens. Monograph on .. | book series | 2 | 2 | 5 | 589 | 0 | 5 | 0.00 | 294.50 | 63.27 | ||
3 | Medicinal Research Reviews | journal | 2.528 Q1 | 150 | 56 | 105 | 12882 | 962 | 104 | 9.68 | 230.04 | 37.78 | |
4 | Reviews of Physiology Biochemistry and Pharmacology | journal | 1.261 Q1 | 70 | 4 | 20 | 784 | 111 | 9 | 6.43 | 196.00 | 0.00 | |
5 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.736 Q1 | 82 | 14 | 45 | 2732 | 146 | 45 | 2.90 | 195.14 | 36.17 | |
6 | Progress in Medicinal Chemistry | journal | 1.230 Q1 | 38 | 6 | 17 | 1127 | 48 | 4 | 1.82 | 187.83 | 0.00 | |
7 | Pharmacology and Therapeutics | journal | 3.586 Q1 | 233 | 160 | 392 | 29808 | 4172 | 392 | 9.64 | 186.30 | 40.22 | |
8 | Drug Resistance Updates | journal | 4.319 Q1 | 132 | 18 | 70 | 3179 | 983 | 70 | 12.31 | 176.61 | 41.98 | |
9 | Advanced Drug Delivery Reviews | journal | 4.163 Q1 | 366 | 170 | 526 | 29564 | 7545 | 481 | 15.06 | 173.91 | 38.15 | |
10 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 4 | 8 | 682 | 1 | 8 | 0.20 | 170.50 | 43.84 | ||
11 | Nano Today | journal | 6.236 Q1 | 175 | 49 | 162 | 7969 | 2551 | 136 | 15.67 | 162.63 | 28.92 | |
12 | Natural Product Reports | journal | 3.552 Q1 | 211 | 65 | 214 | 9801 | 2304 | 208 | 10.66 | 150.78 | 25.41 | |
13 | Drug Metabolism Reviews | journal | 0.944 Q1 | 108 | 25 | 89 | 3488 | 376 | 89 | 4.15 | 139.52 | 39.08 | |
14 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.276 Q4 | 50 | 30 | 26 | 4168 | 24 | 20 | 1.41 | 138.93 | 0.00 | |
15 | Studies in Natural Products Chemistry | book series | 0.160 Q4 | 49 | 89 | 146 | 12353 | 118 | 13 | 0.86 | 138.80 | 0.00 | |
16 | Topics in Medicinal Chemistry | book series | 0.266 Q3 | 15 | 44 | 63 | 5584 | 31 | 44 | 0.50 | 126.91 | 0.00 | |
17 | Handbook of Experimental Pharmacology | journal | 1.489 Q1 | 110 | 106 | 358 | 13405 | 1202 | 158 | 2.33 | 126.46 | 50.00 | |
18 | Critical Reviews in Toxicology | journal | 1.442 Q1 | 129 | 48 | 112 | 5971 | 594 | 109 | 4.19 | 124.40 | 40.24 | |
19 | Current Neuropharmacology | journal | 1.490 Q1 | 103 | 116 | 280 | 14411 | 1277 | 246 | 4.05 | 124.23 | 40.18 | |
20 | Current Medicinal Chemistry | journal | 0.918 Q1 | 202 | 332 | 835 | 40345 | 2886 | 780 | 3.22 | 121.52 | 45.73 | |
21 | Journal of Receptor, Ligand and Channel Research | journal | 0.203 Q3 | 13 | 2 | 6 | 231 | 4 | 6 | 1.00 | 115.50 | 80.00 | |
22 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.606 Q1 | 99 | 21 | 54 | 2386 | 347 | 51 | 6.40 | 113.62 | 41.89 | |
23 | Advanced Therapeutics | journal | 39 | 53 | 0 | 5982 | 0 | 0 | 0.00 | 112.87 | 34.92 | ||
24 | Progress in Drug Research | book series | 0.189 Q3 | 46 | 10 | 65 | 1125 | 16 | 7 | 0.14 | 112.50 | 0.00 | |
25 | Food and Drug Law Journal | journal | 0.231 Q3 | 23 | 19 | 74 | 2066 | 45 | 71 | 0.53 | 108.74 | 35.71 | |
26 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.529 Q2 | 52 | 33 | 88 | 3586 | 192 | 82 | 2.10 | 108.67 | 50.97 | |
27 | Cellular and Molecular Life Sciences | journal | 3.006 Q1 | 261 | 291 | 892 | 31340 | 6199 | 883 | 7.30 | 107.70 | 43.45 | |
28 | Expert Opinion on Therapeutic Targets | journal | 1.470 Q1 | 106 | 91 | 359 | 9798 | 1568 | 333 | 4.30 | 107.67 | 37.54 | |
29 | Current Drug Metabolism | journal | 0.544 Q3 | 122 | 116 | 261 | 12267 | 638 | 240 | 2.38 | 105.75 | 37.90 | |
30 | Current Pharmaceutical Design | journal | 0.703 Q2 | 183 | 567 | 1815 | 57632 | 4871 | 1663 | 2.46 | 101.64 | 42.32 | |
31 | Expert Opinion on Emerging Drugs | journal | 0.977 Q2 | 54 | 29 | 116 | 2879 | 361 | 108 | 3.05 | 99.28 | 32.58 | |
32 | Issues in Toxicology | book series | 0.145 Q4 | 18 | 46 | 150 | 4530 | 60 | 36 | 0.43 | 98.48 | 0.00 | |
33 | Current Drug Targets | journal | 0.825 Q2 | 119 | 171 | 558 | 16711 | 1326 | 491 | 2.22 | 97.73 | 41.62 | |
34 | Expert Opinion on Drug Delivery | journal | 1.337 Q1 | 133 | 96 | 399 | 9346 | 2201 | 375 | 5.18 | 97.35 | 40.05 | |
35 | Advanced healthcare materials | journal | 1.965 Q1 | 140 | 354 | 885 | 34337 | 5748 | 863 | 6.13 | 97.00 | 38.56 | |
36 | Current Pharmacology Reports | journal | 0.803 Q2 | 35 | 42 | 115 | 4016 | 320 | 115 | 2.29 | 95.62 | 41.10 | |
37 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.484 Q1 | 150 | 283 | 496 | 26823 | 2148 | 489 | 4.45 | 94.78 | 45.70 | |
38 | Current Topics in Medicinal Chemistry | journal | 0.878 Q1 | 133 | 242 | 775 | 22746 | 2415 | 671 | 3.09 | 93.99 | 41.81 | |
39 | Current Cancer Drug Targets | journal | 0.875 Q1 | 103 | 87 | 227 | 8117 | 521 | 202 | 2.15 | 93.30 | 41.22 | |
40 | Pharmacological Research | journal | 1.781 Q1 | 169 | 345 | 904 | 31951 | 4950 | 836 | 5.42 | 92.61 | 43.17 | |
41 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 17 | 47 | 1568 | 78 | 43 | 2.18 | 92.24 | 39.68 | ||
42 | Neurotherapeutics | journal | 2.565 Q1 | 136 | 92 | 252 | 8483 | 1460 | 233 | 5.29 | 92.21 | 40.44 | |
43 | Current Topics in Pharmacology | journal | 0.137 Q4 | 8 | 11 | 26 | 994 | 7 | 26 | 0.13 | 90.36 | 41.03 | |
44 | Expert Opinion on Drug Discovery | journal | 1.450 Q1 | 84 | 104 | 305 | 9362 | 1451 | 283 | 4.09 | 90.02 | 37.01 | |
45 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.896 Q2 | 100 | 116 | 405 | 10206 | 1345 | 380 | 3.42 | 87.98 | 45.50 | |
46 | Pharmaceuticals | journal | 1.209 Q1 | 87 | 137 | 216 | 11991 | 872 | 203 | 3.92 | 87.53 | 42.01 | |
47 | Current Gene Therapy | journal | 1.008 Q1 | 80 | 41 | 139 | 3484 | 338 | 128 | 2.16 | 84.98 | 42.50 | |
48 | RSC Drug Discovery Series | book series | 0.181 Q4 | 13 | 76 | 277 | 6428 | 103 | 133 | 0.33 | 84.58 | 0.00 | |
49 | Current Molecular Pharmacology | journal | 0.774 Q2 | 49 | 34 | 99 | 2857 | 178 | 83 | 1.22 | 84.03 | 45.99 | |
50 | Antiviral Chemistry and Chemotherapy | journal | 0.349 Q3 | 59 | 19 | 30 | 1552 | 37 | 27 | 1.70 | 81.68 | 38.03 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®